Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2340070 | 0.83 | ALOX5 (0.61) | ALOX5KMT2AACHE | |
| SCHEMBL10693720 | 0.82 | ALOX5 (1.00) | ALOX5MEN1KMT2APTGS1PTGS2 | |
| SCHEMBL6462689 | 0.78 | ACHE (0.51) | MEN1KMT2ATDP1PLA2G1BATG4B | |
| SCHEMBL3722809 | 0.75 | ALDH1A1 (0.56) | ALOX5MEN1KMT2ATDP1ACHE | |
| SCHEMBL17774456 | 0.75 | ALOX5 (0.60) | ALOX5MEN1KMT2APTGS1PTGS2 | |
| SCHEMBL2336992 | 0.74 | ALOX5 (0.41) | ALOX5PTGS2 | |
| SCHEMBL7040094 | 0.74 | TDP1 (0.59) | MEN1KMT2ATDP1CNR2ACHE | |
| SCHEMBL10905939 | 0.73 | TDP1 (0.69) | MEN1KMT2ATDP1CNR2ACHE | |
| SCHEMBL490533 | 0.73 | NPC1 (0.52) | MEN1KMT2APLA2G1BATG4BCNR2 | |
| SCHEMBL9707675 | 0.72 | ALOX5 (0.72) | ALOX5PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9210928-B2 | Plant development control composition | SYNGENTA CROP PROTECTION, LLC (US) | 2015-12-15 | — | — | US | disclosed |
| US-20110301028-A1 | PLANT DEVELOPMENT CONTROL COMPOSITION | SYNGENTA CROP PROTECTION, LLC (US) | 2011-12-08 | — | — | US | disclosed |
| EP-2358197-A2 | PLANT DEVELOPMENT CONTROL COMPOSITION | Syngenta Participations AG (CH) | 2011-08-24 | — | — | EP | disclosed |
| WO-2010055316-A2 | PLANT DEVELOPMENT CONTROL COMPOSITION | THE UNIVERSITY OF WARWICK (GB) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010055310-A1 | HERBICIDAL COMPOSITIONS | THE UNIVERSITY OF WARWICK (GB) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301028-A1 | PLANT DEVELOPMENT CONTROL COMPOSITION | MSL1, OXSR1, OSR1 | ALOX5 3171/4885MEN1 4293/4885KMT2A 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.